Reduced hippocampal glutamate in Alzheimer disease

“Mini-mental state”

Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282 · see citing works

An Algorithm for Least-Squares Estimation of Nonlinear Parameters

Marquardt, D. W. (1963) · Journal of the Society for Industrial and Applied Mathematics · doi:10.1137/0111030 · Cited by 30,728 · see citing works

Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily Living

Lawton, M. P., & Brody, E. M. (1969) · The Gerontologist · doi:10.1093/geront/9.3_part_1.179 · Cited by 18,540 · see citing works

Current concepts in mild cognitive impairment

Petersen, R. C., Doody, R., Kurz, A., Mohs, R. C., Morris, J. C., Rabins, P. V., Ritchie, K., Rossor, M., Thal, L., & Winblad, B. (2001) · Archives of Neurology · doi:10.1001/archneur.58.12.1985 · Cited by 4,781 · see citing works

Cornell scale for depression in dementia

Alexopoulos, G. S., Abrams, R. C., Young, R. C., & Shamoian, C. A. (1988) · Biological Psychiatry · doi:10.1016/0006-3223(88)90038-8 · Cited by 2,678 · see citing works

Clinical Dementia Rating: A Reliable and Valid Diagnostic and Staging Measure for Dementia of the Alzheimer Type

Morris, J. C. (1997) · International Psychogeriatrics · doi:10.1017/s1041610297004870 · Cited by 1,641 · see citing works

Natural Oligomers of the Alzheimer Amyloid-β Protein Induce Reversible Synapse Loss by Modulating an NMDA-Type Glutamate Receptor-Dependent Signaling Pathway

Shankar, G. M., Bloodgood, B. L., Townsend, M., Walsh, D. M., Selkoe, D. J., & Sabatini, B. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4970-06.2007 · Cited by 1,592 · see citing works

The Return of the Frequency Sweep: Designing Adiabatic Pulses for Contemporary NMR

Garwood, M., & DelaBarre, L. J. (2001) · Journal of Magnetic Resonance · doi:10.1006/jmre.2001.2340 · Cited by 954 · see citing works

Multimodal Image Coregistration and Partitioning—A Unified Framework

Ashburner, J., & Friston, K. J. (1997) · NeuroImage · doi:10.1006/nimg.1997.0290 · Cited by 932 · see citing works

Multinuclear NMR Studies on the Energy Metabolism of Glial and Neuronal Cells

Brand, A., Richter‐Landsberg, C., & Leibfritz, D. (1994) · Developmental Neuroscience · doi:10.1159/000111347 · Cited by 889 · see citing works

In vivo proton spectroscopy in presence of eddy currents

Klose, U. (1990) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910140104 · Cited by 582 · see citing works

Vascular risk factors, incidence of MCI, and rates of progression to dementia

Solfrizzi, V., Panza, F., Colacicco, A. M., D’Introno, A., Capurso, C., Torres, F., Grigoletto, F., Maggi, S., Del Parigi, A., Reiman, E. M., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000144281.38555.e3 · Cited by 530 · see citing works

Regional metabolic patterns in mild cognitive impairment and Alzheimer’s disease

Kantarci, K., Jack, C. R., Xu, Y., Campeau, N. G., O’Brien, P. C., Smith, G. E., Ivnik, R. J., Boeve, B. F., Kokmen, E., Tangalos, E. G., et al. (2000) · Neurology · doi:10.1212/wnl.55.2.210 · Cited by 460 · see citing works

In vivo ¹ H NMR spectroscopy of the human brain at 7 T

Tkáč, I., Andersen, P., Adriany, G., Merkle, H., Uǧurbil, K., & Gruetter, R. (2001) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1213 · Cited by 394 · see citing works

Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy.

Miller, B. L., Moats, R. A., Shonk, T. K., Ernst, T., Woolley, S. R., & Ross, B. D. (1993) · Radiology · doi:10.1148/radiology.187.2.8475286 · Cited by 358 · see citing works

Proposed Factor Structure of the Geriatric Depression Scale

Sheikh, J. I., Yesavage, J. A., Brooks, J. O., Friedman, L., Gratzinger, P., Hill, R. D., Zadeik, A., & Crook, T. H. (1991) · International Psychogeriatrics · doi:10.1017/s1041610291000480 · Cited by 290 · see citing works

In vivo quantification of brain metabolites by 1H-MRS using water as an internal standard

Christiansen, P., Henriksen, O. M., Stubgaard, M., Gideon, P., & Larsson, H. B. W. (1993) · Magnetic Resonance Imaging · doi:10.1016/0730-725x(93)90418-d · Cited by 285 · see citing works

Rapid Three-Dimensional MR Imaging Using the FLASH Technique

Frahm, J., Haase, A., & Matthaei, D. (1986) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-198603000-00046 · Cited by 273 · see citing works

Magnetic resonance spectroscopy in AD

Valenzuela, M., & Sachdev, P. S. (2001) · Neurology · doi:10.1212/wnl.56.5.592 · Cited by 256 · see citing works

Age-related glutamate and glutamine concentration changes in normal human brain: 1H MR spectroscopy study at 4 T

Kaiser, L. G., Schuff, N., Cashdollar, N., & Weiner, M. W. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.07.001 · Cited by 251 · see citing works

Alzheimer's disease: Glutamate depletion in the hippocampal perforant pathway zone

Hyman, B. T., Hoesen, G. W. V., & Damásio, A. R. (1987) · Annals of Neurology · doi:10.1002/ana.410220110 · Cited by 219 · see citing works

Abnormal cerebral metabolite concentrations in patients with probable alzheimer disease

Moats, R. A., Ernst, T. M., Shonk, T. K., & Ross, B. D. (1994) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910320115 · Cited by 216 · see citing works

Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease

Kantarci, K., Weigand, S. D., Petersen, R. C., Boeve, B. F., Knopman, D. S., Gunter, J. L., Reyes, D. A., Shiung, M. S., O’Brien, P. C., Smith, G. E., et al. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.06.018 · Cited by 213 · see citing works

Changes of hippocampal N-acetyl aspartate and volume in Alzheimer's disease

Schuff, N. W., Amend, D. L., Ezekiel, F., Steinman, S., Tanabe, J., Norman, D. M., Jagust, W. J., Kramer, J. H., Mastrianni, J. A., Fein, G., et al. (1997) · Neurology · doi:10.1212/wnl.49.6.1513 · Cited by 203 · see citing works

Monitoring disease progression in transgenic mouse models of Alzheimer's disease with proton magnetic resonance spectroscopy

Marjańska, M., Curran, G. L., Wengenack, T. M., Henry, P., Bliss, R., Poduslo, J. F., Jack, C. R., Uǧurbil, K., & Garwood, M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505513102 · Cited by 198 · see citing works

Frontotemporal dementia and early Alzheimer disease: differentiation with frontal lobe H-1 MR spectroscopy.

Ernst, T., Chang, L., Melchor, R., & Mehringer, C. M. (1997) · Radiology · doi:10.1148/radiology.203.3.9169712 · Cited by 192 · see citing works

Morphological criteria for the recognition of Alzheimer's disease and the distribution pattern of cortical changes related to this disorder

Braak, H., & Braak, E. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)90032-9 · Cited by 181 · see citing works

Gray and white matter changes in Alzheimer's disease: a diffusion tensor imaging study

Rose, S. E., Janke PhD, A. L., & Chalk, J. B. (2008) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21231 · Cited by 178 · see citing works

Longitudinal decline of the neuronal marker N-acetyl aspartate in Alzheimer's disease

Elfar Adalsteinsson, A., Sullivan, E. V., Kleinhans, N. M., Spielman, D. M., & Pfefferbaum, A. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02246-7 · Cited by 174 · see citing works

Paradoxical Upregulation of Glutamatergic Presynaptic Boutons during Mild Cognitive Impairment

Bell, K. F. S., Bennett, D. A., & Cuello, A. C. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.3269-07.2007 · Cited by 145 · see citing works

Longitudinal quantitative proton magnetic resonance spectroscopy of the hippocampus in Alzheimer's disease

Dixon, R. M. (2002) · Brain · doi:10.1093/brain/awf226 · Cited by 128 · see citing works

Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease

Ackl, N., Ising, M., Schreiber, Y. A., Atiya, M., Sonntag, A., & Auer, D. P. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.04.035 · Cited by 125 · see citing works

Quality: quantification improvement by converting lineshapes to the lorentzian type

de Graaf, A. A., van Dijk, J. E., & BoéE, W. M. M. J. (1990) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910130302 · Cited by 124 · see citing works

Proton MR spectroscopy in mild cognitive impairment and Alzheimer disease: comparison of 1.5 and 3 T.

Kantarci, K., Reynolds, G., Petersen, R. C., Boeve, B. F., Knopman, D. S., Edland, S. D., Smith, G. E., Ivnik, R. J., Tangalos, E. G., & Jack, C. R. (2003) · PubMed Central · Cited by 122 · see citing works

Decreased glutamate + glutamine in Alzheimer’s disease detected in vivo with ¹ H-MRS at 0.5 T

Antuono, P. G., Jones, J. L., Wang, Y., & Li, S.-J. (2001) · Neurology · doi:10.1212/wnl.56.6.737 · Cited by 119 · see citing works

Reduced glutamate neurotransmission in patients with Alzheimer's disease?an in vivo 13C magnetic resonance spectroscopy study

Lin, A., Shic, F., Enriquez, C. M., & Ross, B. D. (2003) · Magnetic Resonance Materials in Physics Biology and Medicine · doi:10.1007/s10334-003-0004-x · Cited by 115 · see citing works

Proton MR spectroscopic study at 3 Tesla on glutamate/glutamine in Alzheimer’s disease

Hattori, N., Abe, K., Sakoda, S., & Sawada, T. (2002) · Neuroreport · doi:10.1097/00001756-200201210-00041 · Cited by 112 · see citing works

Regional distribution of amino acid transmitters in postmortem brains of presenile and senile dementia of Alzheimer type

Sasaki, H., Muramoto, O., Kanazawa, I., Arai, H., Kosaka, K., & Iizuka, R. (1986) · Annals of Neurology · doi:10.1002/ana.410190307 · Cited by 110 · see citing works

Multi-component apparent diffusion coefficients in human brain: Relationship to spin-lattice relaxation

Mulkern, R. V., Zengingönül, H. P., Robertson, R. L., Bogner, P., Zou, K. H., Guðbjartsson, H., Guttmann, C. R. G., Holtzman, D. H., Kyriakos, W. E., Jolesz, F. A., et al. (2000) · Magnetic Resonance in Medicine · doi:10.1002/1522-2594(200008)44:2 · Cited by 109 · see citing works

Time and frequency domain analysis of NMR data compared: An application to 1D 1H spectra of lipoproteins

van den Boogaart, A., Ala‐Korpela, M., Jokisaari, J. P., & Griffiths, J. R. (1994) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910310402 · Cited by 107 · see citing works

Does Alzheimer’s Disease Affect Hippocampal Asymmetry? Evidence from a Cross-Sectional and Longitudinal Volumetric MRI Study

Barnes, J., Scahill, R. I., Schott, J. M., Frost, C. D., Rossor, M. N., & Fox, N. C. (2005) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000084560 · Cited by 105 · see citing works

Quantification of cerebral metabolites in glioma patients with proton MR spectroscopy using T2 relaxation time correction

Isobe, T., Matsumura, A., Anno, I., Yoshizawa, T., Nagatomo, Y., Itai, Y., & Nose, T. (2002) · Magnetic Resonance Imaging · doi:10.1016/s0730-725x(02)00500-3 · Cited by 105 · see citing works

Decrease of N -acetylaspartate in the MTL correlates with cognitive decline of AD patients

Jessen, F., Block, W., Träber, F., Keller, E., Flacke, S., Lamerichs, R. M. J. N., Schild, H. H., & Heun, R. (2001) · Neurology · doi:10.1212/wnl.57.5.930 · Cited by 94 · see citing works

Quantitative proton short‐echo‐time LASER spectroscopy of normal human white matter and hippocampus at 4 Tesla incorporating macromolecule subtraction

Kassem, M. N. E., & Bartha, R. (2003) · Magnetic Resonance in Medicine · doi:10.1002/mrm.10443 · Cited by 84 · see citing works

Psychometric Properties of the Mattis Dementia Rating Scale

Smith, G. E., Ivnik, R. J., Malec, J. F., Kokmen, E., Tangalos, E. G., & Petersen, R. C. (1994) · Assessment · doi:10.1177/1073191194001002002 · Cited by 80 · see citing works

Low Striatal Glutamate Levels Underlie Cognitive Decline in the Elderly: Evidence from In Vivo Molecular Spectroscopy

Zahr, N. M., Mayer, D., Pfefferbaum, A., & Sullivan, E. V. (2008) · Cerebral Cortex · doi:10.1093/cercor/bhm250 · Cited by 79 · see citing works

Magnetic resonance angiography of the rat cerebrovascular system without the use of contrast agents

Reese, T., Bochelen, D., Sauter, A., Beckmann, N., & Rudin, M. (1999) · NMR in Biomedicine · doi:10.1002/(sici)1099-1492(199906)12:4 · Cited by 63 · see citing works

In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease

Frederick, B. B., Lyoo, I. K., Satlin, A., Ahn, K. H., Kim, M. J., Yurgelun-Todd, D. A., Cohen, B. M., & Renshaw, P. F. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.08.013 · Cited by 56 · see citing works

High field 1H MRS of the hippocampus after donepezil treatment in Alzheimer disease

Bartha, R., Smith, M., Rupsingh, R., Rylett, R. J., Wells, J., & BORRIE, M. J. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.12.011 · Cited by 54 · see citing works

Shortening of hippocampal spin-spin relaxation time in probable Alzheimer's disease: a 1H magnetic resonance spectroscopy study

Haley, A. P., Knight‐Scott, J., Fuchs, K. L., Simnad, V. I., & Manning, C. A. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.01.031 · Cited by 29 · see citing works

Untitled work

Basser (2000) · doi:10.1002/1522-2594(200010)44:4

Clinical Proton MR Spectroscopy in Central Nervous System Disorders

Öz, G., Alger, J. R., Barker, P. B., Bartha, R., Bizzi, A., Boesch, C., Bolan, P. J., Brindle, K. M., Cudalbu, C., Di̇nçer, A., et al. (2014) · Radiology · doi:10.1148/radiol.13130531 · Cited by 663 · see citing works

Glutamate metabolism and recycling at the excitatory synapse in health and neurodegeneration

Andersen, J. V., Markussen, K. H., Jakobsen, E., Schousboe, A., Waagepetersen, H. S., Rosenberg, P. A., & Aldana, B. I. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108719 · Cited by 375 · see citing works

Magnetic Resonance Spectroscopy to Assess NeuroInflammation and Neuropathic Pain

Chang, L., Munsaka, S. M., Kraft-Terry, S. D., & Ernst, T. M. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9460-x · Cited by 306 · see citing works

On the early diagnosis of Alzheimer's Disease from multimodal signals: A survey

Alberdi, A., Aztiria, A., & Basarab, A. (2016) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2016.06.003 · Cited by 222 · see citing works

Tau oligomers and aggregation in Alzheimer’s disease

Meraz‐Ríos, M. A., León, K. I. L.-D., Campos‐Peña, V., Anda-Hernández, M. A. D., & Mena‐López, R. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06511.x · Cited by 193 · see citing works

Alzheimer’s disease: Targeting the glutamatergic system

Conway, M. E. (2020) · Biogerontology · doi:10.1007/s10522-020-09860-4 · Cited by 180 · see citing works

‘Too much good news’ – are Alzheimer mouse models trying to tell us how to prevent, not cure, Alzheimer's disease?

Zahs, K. R., & Ashe, K. H. (2010) · Trends in Neurosciences · doi:10.1016/j.tins.2010.05.004 · Cited by 174 · see citing works

Hippocampal plasticity during the progression of Alzheimer’s disease

Mufson, E. J., Mahady, L. J., Waters, D., Counts, S., Perez, S. E., DeKosky, S. T., Ginsberg, S. D., Ikonomović, M. D., Scheff, S. W., & Binder, L. I. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.03.006 · Cited by 172 · see citing works

Magnetic resonance imaging of the Amine–Proton EXchange (APEX) dependent contrast

Jin, T., Wang, P., Zong, X., & Kim, S. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.08.014 · Cited by 169 · see citing works

Toward a Predictive Model of Alzheimer’s Disease Progression Using Capillary Electrophoresis–Mass Spectrometry Metabolomics

Ibáñez, C., Simó, C., Martín‐Álvarez, P. J., Kivipelto, M., Winblad, B. G., Cedazo-Mı́nguez, Á., & Cifuentes, A. (2012) · Analytical Chemistry · doi:10.1021/ac301243k · Cited by 166 · see citing works

The Dual Role of Glutamatergic Neurotransmission in Alzheimer’s Disease: From Pathophysiology to Pharmacotherapy

Bukke, V. N., Moola, A., Villani, R., Romano, A. D., Wawrzyniak, A., Balawender, K., Orkisz, S., Beggiato, S., Serviddio, G., & Cassano, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207452 · Cited by 160 · see citing works

Na+ and K+ ion imbalances in Alzheimer's disease

Vitvitsky, V., Garg, S. K., Keep, R. F., Albin, R. L., & Banerjee, R. V. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.07.004 · Cited by 162 · see citing works

Imaging of glutamate neurotransmitter alterations in Alzheimer's disease

Haris, M., Nath, K., Cai, K., Singh, A. K., Crescenzi, R. L., Kogan, F., Verma, G., Reddy, S., Hariharan, H., Melhem, E. R., et al. (2012) · NMR in Biomedicine · doi:10.1002/nbm.2875 · Cited by 147 · see citing works

Altered synapses and gliotransmission in Alzheimer's disease and AD model mice

Mitew, S., Kirkcaldie, M. T. K., Dickson, T. C., & Vickers, J. C. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.04.010 · Cited by 138 · see citing works

Magnetic resonance spectroscopy in mild cognitive impairment: Systematic review and meta-analysis

Tumati, S., Martens, S., & Aleman, A. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.08.004 · Cited by 132 · see citing works

Glutathione relates to neuropsychological functioning in mild cognitive impairment

Duffy, S. L., Lagopoulos, J., Hickie, I. B., Diamond, K., Graeber, M. B., Lewis, S. J. G., & Naismith, S. L. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.01.005 · Cited by 130 · see citing works

Brain Glutamate Levels Are Decreased in Alzheimer’s Disease: A Magnetic Resonance Spectroscopy Study

Fayed, N., Modrego, P. J., Rojas-Salinas, G., & Aguilar, K. (2011) · American Journal of Alzheimer's Disease & Other Dementias® · doi:10.1177/1533317511421780 · Cited by 128 · see citing works

Glutamate-glutamine and GABA in brain of normal aged and patients with cognitive impairment

Huang, D., Liu, D., Yin, J., Qian, T., Shrestha, S., & Ni, H. (2016) · European Radiology · doi:10.1007/s00330-016-4669-8 · Cited by 127 · see citing works

Amyloid Beta-Related Alterations to Glutamate Signaling Dynamics During Alzheimer’s Disease Progression

Findley, C. A., Bartke, A., Hascup, K. N., & Hascup, E. R. (2019) · ASN NEURO · doi:10.1177/1759091419855541 · Cited by 124 · see citing works

Glutamatergic alterations and mitochondrial impairment in a murine model of Alzheimer disease

Cassano, T., Serviddio, G., Gaetani, S., Romano, A., Dipasquale, P., Cianci, S., Bellanti, F., Laconca, L., Romano, A. D., Padalino, I., et al. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.09.021 · Cited by 99 · see citing works

Glutamate and Mitochondria: Two Prominent Players in the Oxidative Stress-Induced Neurodegeneration

Cassano, T., Pace, L., Bedse, G., Lavecchia, A. M., Marco, F. D., Gaetani, S., & Serviddio, G. (2015) · Current Alzheimer Research · doi:10.2174/1567205013666151218132725 · Cited by 95 · see citing works

Neurometabolites and associations with cognitive deficits in mild cognitive impairment: a magnetic resonance spectroscopy study at 7 Tesla

Oeltzschner, G., Wijtenburg, S. A., Mikkelsen, M. E., Edden, R. A. E., Barker, P. B., Joo, J. H., Leoutsakos, J., Rowland, L. M., Workman, C. I., & Smith, G. S. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.09.027 · Cited by 83 · see citing works

Magnetic resonance spectroscopy in Alzheimer’s disease

Kantarci, K., & Radford, G. (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s35440 · Cited by 83 · see citing works

Posterior cingulate γ-aminobutyric acid and glutamate/glutamine are reduced in amnestic mild cognitive impairment and are unrelated to amyloid deposition and apolipoprotein E genotype

Riese, F., Gietl, A. F., Zoelch, N., Henning, A., Tuura, R., Kälin, A. M., Leh, S. E., Buck, A., Warnock, G., Edden, R. A. E., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.07.030 · Cited by 81 · see citing works

Serum Amino Acid Profiles in Normal Subjects and in Patients with or at Risk of Alzheimer Dementia

Corso, G., Cristofano, A., Sapere, N., la Marca, G., Angiolillo, A., Vitale, M., Fratangelo, R., Lombardi, T., Porcile, C., Intrieri, M., et al. (2017) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000466688 · Cited by 79 · see citing works

A comprehensive multiomics approach toward understanding the relationship between aging and dementia

Currais, A. J. M., Goldberg, J., Farrokhi, C. B., Chang, M. W., Prior, M., Dargusch, R., Daugherty, D., Armando, A. M., Quehenberger, O., Maher, P. A., et al. (2015) · Aging · doi:10.18632/aging.100838 · Cited by 77 · see citing works

In vivo measurement of glutamate loss is associated with synapse loss in a mouse model of tauopathy

Crescenzi, R., DeBrosse, C., Nanga, R. P. R., Reddy, S., Haris, M., Hariharan, H., Iba, M., Lee, V. M. Y., Detre, J. A., Borthakur, A., et al. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2014.06.067 · Cited by 73 · see citing works

Glutamine metabolism in diseases associated with mitochondrial dysfunction

Bornstein, R., Mulholland, M. T., Sedensky, M. M., Morgan, P. G., & Johnson, S. C. (2023) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2023.103887 · Cited by 71 · see citing works

Whole-brain patterns of 1H-magnetic resonance spectroscopy imaging in Alzheimer's disease and dementia with Lewy bodies

Su, L., Blamire, A. M., Watson, R., He, J., Hayes, L., & O'Brien, J. T. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.140 · Cited by 70 · see citing works

Advances in MRI Biomarkers for the Diagnosis of Alzheimer’s Disease

Kehoe, E. G., McNulty, J. P., Mullins, P. G., & Bokde, A. L. W. (2014) · Biomarkers in Medicine · doi:10.2217/bmm.14.42 · Cited by 65 · see citing works

Cell adhesion molecules in Alzheimer's disease

Nielsen, H. M., & Wennström, M. (2012) · Degenerative Neurological and Neuromuscular Disease · doi:10.2147/dnnd.s19829 · Cited by 64 · see citing works

Absolute Quantification in Proton Magnetic Resonance Spectroscopy Is Useful to Differentiate Amnesic Mild Cognitive Impairment from Alzheimer’s Disease and Healthy Aging

Watanabe, T., Shiino, A., & Akiguchi, I. (2010) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000318750 · Cited by 63 · see citing works

Glutamate metabolism is impaired in transgenic mice with tau hyperphosphorylation

Nilsen, L. H., Rae, C., Ittner, L. M., Götz, J., & Sonnewald, U. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.212 · Cited by 62 · see citing works

Reversal of Metabolic Deficits by Lipoic Acid in a Triple Transgenic Mouse Model of Alzheimer's Disease: A 13C NMR Study

Sancheti, H., Kanamori, K., Patil, I., Diaz-Brinton, R., Ross, B., & Cadenas, E. (2014) · Journal of Cerebral Blood Flow and Metabolism · doi:10.1038/jcbfm.2013.196 · Cited by 60 · see citing works

Increased glutamate in the hippocampus after galantamine treatment for Alzheimer disease

Penner, J., Rupsingh, R., Smith, M., Wells, J., BORRIE, M. J., & Bartha, R. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.10.007 · Cited by 57 · see citing works

1H NMR Metabolomic Signatures in Five Brain Regions of the AβPPswe Tg2576 Mouse Model of Alzheimer's Disease at Four Ages

Lalande-Martin, J., Halley, H., Balayssac, S., Gilard, V., Dejean, S., Martino, R., Francès, B., Lassalle, J., & Malet‐Martino, M. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-130023 · Cited by 58 · see citing works

NSCs promote hippocampal neurogenesis, metabolic changes and synaptogenesis in APP/PS1 transgenic mice

Zhang, W., Gu, G., Zhang, Q., Liu, J., Zhang, B., Guo, Y. C., Wang, M., Gong, Q., & Xu, J. (2017) · Hippocampus · doi:10.1002/hipo.22794 · Cited by 57 · see citing works

Reduced Hippocampal Glutamate and Posterior Cingulate N-Acetyl Aspartate in Mild Cognitive Impairment and Alzheimer’s Disease Is Associated with Episodic Memory Performance and White Matter Integrity in the Cingulum: A Pilot Study

Wong, D. Y., Atiya, S., Fogarty, J., Montero‐Odasso, M., Pasternak, S., Brymer, C., BORRIE, M. J., & Bartha, R. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-190773 · Cited by 56 · see citing works

Hippocampal metabolites in asthma and their implications for cognitive function

Kroll, J. L., Steele, A. M., Pinkham, A. E., Choi, C., Khan, D. A., Patel, S. V., Chen, J. R., Aslan, S., Brown, E. S., & Ritz, T. (2018) · NeuroImage Clinical · doi:10.1016/j.nicl.2018.04.012 · Cited by 55 · see citing works

Higher Glutamate + Glutamine and Reduction of N-acetylaspartate in Posterior Cingulate According to Age Range in Patients with Cognitive Impairment and/or Pain

Fayed, N. M., Andres, E. M., Viguera, L., Modrego, P. J., & García‐Campayo, J. (2014) · Academic Radiology · doi:10.1016/j.acra.2014.04.009 · Cited by 54 · see citing works

Feasibility and reproducibility of neurochemical profile quantification in the human hippocampus at 3 T

Bednařík, P., Moheet, A. A., Deelchand, D. K., Emir, U. E., Eberly, L. E., Bareš, M., Seaquist, E. R., & Öz, G. (2015) · NMR in Biomedicine · doi:10.1002/nbm.3309 · Cited by 54 · see citing works

Errors in 1H‐MRS estimates of brain metabolite concentrations caused by failing to take into account tissue‐specific signal relaxation

Gasparovic, C., Chen, H., & Mullins, P. G. (2018) · NMR in Biomedicine · doi:10.1002/nbm.3914 · Cited by 53 · see citing works

Proton and Phosphorus Magnetic Resonance Spectroscopy of a Mouse Model of Alzheimer's Disease

Mlynárik, V., Cacquevel, M., Sun-Reimer, L., Janssens, S., Cudalbu, C., Lei, H., Schneider, B. L., Aebischer, P., & Rolf Gruetter, A. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-112072 · Cited by 52 · see citing works

Electroacupuncture ameliorate learning and memory by improving N-acetylaspartate and glutamate metabolism in APP/PS1 mice

Lin, R., Li, L., Zhang, Y., Huang, S., Chen, S., Shi, J., Zhuo, P., Jin, H., Li, Z., Liu, W., et al. (2018) · Biological Research · doi:10.1186/s40659-018-0166-7 · Cited by 52 · see citing works

Proton MR Spectroscopy–Detectable Major Neurotransmitters of the Brain: Biology and Possible Clinical Applications

Agarwal, N., & Renshaw, P. F. (2011) · American Journal of Neuroradiology · doi:10.3174/ajnr.a2587 · Cited by 51 · see citing works

Modulating the Balance of Synaptic and Extrasynaptic NMDA Receptors Shows Positive Effects against Amyloid-β-Induced Neurotoxicity

Huang, Y. Y., Shen, W., Su, J., Cheng, B., Li, D., Liu, G., Zhou, W., & Zhang, Y. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161186 · Cited by 50 · see citing works

Activity of Selected Group of Monoterpenes in Alzheimer’s Disease Symptoms in Experimental Model Studies—A Non-Systematic Review

Wojtunik‐Kulesza, K. A., Rudkowska, M., Kasprzak‐Drozd, K., Oniszczuk, A., & Borowicz, K. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147366 · Cited by 50 · see citing works

Down‐regulation of glutamatergic terminals (VGLUT1) driven by Aβ in Alzheimer's disease

Rodriguez‐Perdigon, M., Tordera, R. M., Gil-Bea, F. J., Gereñu, G., Ramírez, M. J., & Solas, M. (2016) · Hippocampus · doi:10.1002/hipo.22607 · Cited by 47 · see citing works

Magnetic Resonance Spectroscopy in Common Dementias

Kantarci, K. (2013) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2012.10.004 · Cited by 47 · see citing works

Protein and amino acid supplementation in older humans

Fukagawa, N. K. (2013) · Amino Acids · doi:10.1007/s00726-013-1480-6 · Cited by 43 · see citing works

Altered neurochemical profile in the M cGill‐ R ‐ T hy1‐ APP rat model of A lzheimer's disease: a longitudinal in vivo 1 H MRS study

Nilsen, L. H., Melø, T. M., Sæther, O., Witter, M. P., & Sonnewald, U. (2012) · Journal of Neurochemistry · doi:10.1111/jnc.12003 · Cited by 43 · see citing works

Neurochemicals, Behaviours and Psychiatric Perspectives of Neurological Diseases

Choudhury, A., Sahu, T., Ramanujam, P. L., Banerjee, A. K., Chakraborty, I., Arun Kumar, R., & Arora, N. (2018) · Neuropsychiatry · doi:10.4172/neuropsychiatry.1000361 · Cited by 41 · see citing works

The role of Smo-Shh/Gli signaling activation in the prevention of neurological and ageing disorders

Prajapati, A., Mehan, S., & Khan, Z. (2023) · Biogerontology · doi:10.1007/s10522-023-10034-1 · Cited by 39 · see citing works

Glutamate: Molecular Mechanisms and Signaling Pathway in Alzheimer’s Disease, a Potential Therapeutic Target

Puranik, N., & Song, M. (2024) · Molecules · doi:10.3390/molecules29235744 · Cited by 45 · see citing works

Decreased Glutamate Levels in Patients with Amnestic Mild Cognitive Impairment: An sLASER Proton MR Spectroscopy and PiB‐PET Study

Zeydan, B., Deelchand, D. K., Tosakulwong, N., Lesnick, T. G., Kantarci, O. H., Machulda, M. M., Knopman, D. S., Lowe, V. J., Jack, C. R., Petersen, R. C., et al. (2017) · Journal of Neuroimaging · doi:10.1111/jon.12454 · Cited by 37 · see citing works

Regional proton magnetic resonance spectroscopy patterns in dementia with Lewy bodies

Graff‐Radford, J., Boeve, B. F., Murray, M. E., Ferman, T. J., Tosakulwong, N., Lesnick, T. G., Maroney‐Smith, M., Senjem, M. L., Gunter, J. L., Smith, G. E., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.01.001 · Cited by 36 · see citing works

Increased hippocampal CA1 density of serotonergic terminals in a triple transgenic mouse model of Alzheimer's disease: an ultrastructural study

Noristani, H. N., Meadows, R. S., Olabarria, M., Verkhratsky, A., & Rodríguez, J. J. (2011) · Cell Death and Disease · doi:10.1038/cddis.2011.79 · Cited by 36 · see citing works

Age dependency of mGluR5 availability in 5xFAD mice measured by PET

Lee, M., Lee, H., Jeong, Y. J., Oh, S. J., Kang, K. J., Han, S. J., Nam, K. R., Lee, Y. J., Lee, K. C., Ryu, Y. H., et al. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.08.006 · Cited by 34 · see citing works

MRS in neurodegenerative dementias, prodromal syndromes and at‐risk states: A systematic review of the literature

McKiernan, E. F., Su, L., & O'Brien, J. T. (2023) · NMR in Biomedicine · doi:10.1002/nbm.4896 · Cited by 33 · see citing works

Increased astroglial activity and reduced neuronal function across brain in AβPP-PS1 mouse model of Alzheimer’s disease

Patel, A. B., Tiwari, V., Veeraiah, P., & Saba, K. (2017) · Journal of Cerebral Blood Flow and Metabolism · doi:10.1177/0271678x17709463 · Cited by 25 · see citing works

Glutamatergic dysfunction in neurodegenerative diseases focusing on Parkinson's disease: Role of glutamate modulators

Almohmadi, N. H., Al-Kuraishy, H. M., Al-Gareeb, A. I., Albuhadily, A. K., Abdelaziz, A. M., Jabir, M. S., Alexiou, A. T., Papadakis, M., & Batiha, G. E. (2025) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2025.111349 · Cited by 35 · see citing works

Optimized in vivo brain glutamate measurement using long‐echo‐time semi‐LASER at 7 T

Wong, D. Y., Schranz, A. L., & Bartha, R. (2018) · NMR in Biomedicine · doi:10.1002/nbm.4002 · Cited by 32 · see citing works

GABA and glutamate moderate beta-amyloid related functional connectivity in cognitively unimpaired old-aged adults

Quevenco, F. C., Schreiner, S. J., Preti, M. G., Bergen, J. M. G. V., Kirchner, T., Wyss, M. T., Steininger, S. C., Gietl, A. F., Leh, S. E., Buck, A., et al. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.101776 · Cited by 32 · see citing works

Metabolomics in aging research: aging markers from organs

Fang, W., Chen, S., Jin, X., Liu, S., Cao, X., & Liu, B. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1198794 · Cited by 30 · see citing works

Advances in High-Field Magnetic Resonance Spectroscopy in Alzheimer’s Disease

Zhang, N., Song, X., Bartha, R., Beyea, S., D’Arcy, R. C. N., Zhang, Y., & Rockwood, K. J. (2014) · Current Alzheimer Research · doi:10.2174/1567205011666140302200312 · Cited by 30 · see citing works

Cervical Spondylotic Myelopathy: Metabolite Changes in the Primary Motor Cortex after Surgery

Aleksanderek, I., McGregor, S. M. K., Stevens, T. K., Goncalves, S., Bartha, R., & Duggal, N. (2016) · Radiology · doi:10.1148/radiol.2016152083 · Cited by 29 · see citing works

Cerebral blood flow and metabolic changes in hippocampal regions of a modified rat model with chronic cerebral hypoperfusion

Jian, H., Yi-Fang, W., Qi, L., Huang, X.-S., & Zhang, G. (2012) · Acta Neurologica Belgica · doi:10.1007/s13760-012-0154-6 · Cited by 29 · see citing works

A novel phenoxy thiophene sulphonamide molecule protects against glutamate evoked oxidative injury in a neuronal cell model

Gliyazova, N. S., Huh, E. Y., & Ibeanu, G. C. (2013) · BMC Neuroscience · doi:10.1186/1471-2202-14-93 · Cited by 27 · see citing works

Novel Blood Biomarkers that Correlate with Cognitive Performance and Hippocampal Volumetry: Potential for Early Diagnosis of Alzheimer’s Disease

Hudd, F., Shiel, A., Harris, M., Bowdler, P., McCann, B., Tsivos, D., Wearn, A., Knight, M., Kauppinen, R., Coulthard, E., et al. (2019) · Journal of Alzheimer's Disease · doi:10.3233/jad-180879 · Cited by 26 · see citing works

Magnetic resonance spectroscopy analysis of neurochemical changes in the atrophic hippocampus of APP/PS1 transgenic mice

Liang, S., Huang, J., Liu, W., Jin, H., Li, L., Zhang, X., Nie, B., Lin, R., Tao, J., Zhao, S., et al. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.08.005 · Cited by 26 · see citing works

Miniaturized Electrochemical Sensing Platforms for Quantitative Monitoring of Glutamate Dynamics in the Central Nervous System

Wang, Q., Yang, C., Chen, S., & Li, J. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202406867 · Cited by 26 · see citing works

Role of emerging neuroimaging modalities in patients with cognitive impairment: a review from the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012

Burhan, A. M., Bartha, R., Bocti, C., BORRIE, M. J., Laforce, R. J., Rosa‐Neto, P., & Soucy, J. (2013) · Alzheimer s Research & Therapy · doi:10.1186/alzrt200 · Cited by 24 · see citing works

GABA decrease is associated with degraded neural specificity in the visual cortex of glaucoma patients

Bang, J. W., Parra, C., Yu, K., Wollstein, G., Schuman, J. S., & Chan, K. C. (2023) · Communications Biology · doi:10.1038/s42003-023-04918-8 · Cited by 24 · see citing works

Danggui‐Shaoyao‐San Improves Learning and Memory in Female SAMP8 via Modulation of Estradiol

Huang, Y. Y., Hu, Z.-Y., Yuan, H., Shu, L., Liu, G., Shan-yi, Q., Sun, L., Zhou, W., & Zhang, Y. (2014) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2014/327294 · Cited by 24 · see citing works

Glutamate-Weighted CEST Contrast After Removal of Magnetization Transfer Effect in Human Brain and Rat Brain with Tumor

Debnath, A., Hariharan, H., Nanga, R. P. R., Reddy, R. D., & Singh, A. K. (2020) · Molecular Imaging and Biology · doi:10.1007/s11307-019-01465-9 · Cited by 21 · see citing works

1H MR spectroscopy biomarkers of neuronal and synaptic function are associated with tau deposition in cognitively unimpaired older adults

Kara, F., Joers, J. M., Deelchand, D. K., Park, Y. W., Przybelski, S. A., Lesnick, T. G., Senjem, M. L., Zeydan, B., Knopman, D. S., Lowe, V. J., et al. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.12.010 · Cited by 22 · see citing works

Alzheimer-like brain metabolic and structural features in cholesterol-fed rabbit detected by magnetic resonance imaging

Jin, P., Pan, Y., Pan, Z., Xu, J., Lin, M. T., Sun, Z., Chen, M., & Xu, M. (2018) · Lipids in Health and Disease · doi:10.1186/s12944-018-0705-9 · Cited by 22 · see citing works

Saturation Transfer MRI for Detection of Metabolic and Microstructural Impairments Underlying Neurodegeneration in Alzheimer’s Disease

Orzyłowska, A., & Oakden, W. (2021) · Brain Sciences · doi:10.3390/brainsci12010053 · Cited by 20 · see citing works

Memantine hydrochloride in the treatment of dementia subtypes

Peng, D., Yuan, X., & Zhu, R. (2013) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2013.02.041 · Cited by 21 · see citing works

3T hippocampal glutamate-glutamine complex reflects verbal memory decline in aging

Nikolova, S., Stark, S. M., & Stark, C. E. L. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.01.026 · Cited by 21 · see citing works

Early Differences in Dorsal Hippocampal Metabolite Levels in Males But Not Females in a Transgenic Rat Model of Alzheimer’s Disease

Nilsen, L. H., Melø, T. M., Witter, M. P., & Sonnewald, U. (2013) · Neurochemical Research · doi:10.1007/s11064-013-1222-x · Cited by 20 · see citing works

1 H-Proton Magnetic Resonance Spectroscopy Differentiates Dementia with Lewy Bodies from Alzheimer's Disease

Zhong, X., Shi, H., Shen, Z., Hou, L., Luo, X., Chen, X., Liu, S., Zhang, Y., Zheng, D., Tan, Y. L., et al. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-131517 · Cited by 19 · see citing works

A Longitudinal Study of Cognition, Proton MR Spectroscopy and Synaptic and Neuronal Pathology in Aging Wild-type and AβPPswe-PS1dE9 Mice

Jansen, D., Zerbi, V., Janssen, C. I. F., Dederen, P. J. W. C., Mutsaers, M. P. C., Hafkemeijer, A., Janssen, A.-L., Nobelen, C. L. M., Veltien, A. A., van Asten, J. J. A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063643 · Cited by 19 · see citing works

CEST imaging combined with 1H-MRS reveal the neuroprotective effects of riluzole by improving neurotransmitter imbalances in Alzheimer’s disease mice

Shen, Y., Zhang, X., Liu, S.-Q., Xin, L., Xuan, W., Zhuang, C., Chen, Y., Chen, B., Zheng, X., Wu, R., et al. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01672-3 · Cited by 18 · see citing works

Effects of Ultramicronized Palmitoylethanolamide on Mitochondrial Bioenergetics, Cerebral Metabolism, and Glutamatergic Transmission: An Integrated Approach in a Triple Transgenic Mouse Model of Alzheimer's Disease

Bellanti, F., Bukke, V. N., Moola, A., Villani, R., Scuderi, C., Steardo, L., Palombelli, G., Canese, R., Beggiato, S., Altamura, M., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.890855 · Cited by 18 · see citing works

Clinical benefits of green tea consumption for cognitive dysfunction

Ide, K., & Yamada, H. (2015) · PharmaNutrition · doi:10.1016/j.phanu.2015.07.001 · Cited by 19 · see citing works

Hippocampal Neurochemical Changes in Senescent Mice Induced with Chronic Injection of D-Galactose and NaNO2: An In Vitro High-Resolution NMR Spectroscopy Study at 9.4T

Lin, Y., Yao, J., Chen, Y., Pang, L., Li, H., Cao, Z., You, K., Dai, H., & Wu, R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088562 · Cited by 18 · see citing works

Intracerebral synthesis of glutamine from hyperpolarized glutamate

Mazuel, L., Schulte, R. F., Cladière, A., Spéziale, C., Lagrée, M., Leremboure, M., Jean, B., Durif, F., & Chassain, C. (2016) · Magnetic Resonance in Medicine · doi:10.1002/mrm.26522 · Cited by 18 · see citing works

1H MR spectroscopy of the motor cortex immediately following transcranial direct current stimulation at 7 Tesla

Ryan, K., Wawrzyn, K., Gati, J. S., Chronik, B. A., Wong, D. Y., Duggal, N., & Bartha, R. (2018) · PLoS ONE · doi:10.1371/journal.pone.0198053 · Cited by 18 · see citing works

NCX1 and EAAC1 transporters are involved in the protective action of glutamate in an in vitro Alzheimer's disease-like model

Magi, S., Piccirillo, S., Maiolino, M., Lariccia, V., & Amoroso, S. (2020) · Cell Calcium · doi:10.1016/j.ceca.2020.102268 · Cited by 18 · see citing works

Magnetic resonance spectroscopy and brain volumetry in mild cognitive impairment. A prospective study

Fayed, N. M., Modrego, P. J., García‐Martí, G., Sanz‐Requena, R., & Martí‐Bonmatí, L. (2016) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2016.12.010 · Cited by 18 · see citing works

The relationship between measurement of in vivo brain glutamate and markers of iron metabolism: A proton magnetic resonance spectroscopy study in healthy adults

Burger, A., Kotze, M. J., Stein, D. J., van Rensburg, S. J., & Howells, F. M. (2019) · European Journal of Neuroscience · doi:10.1111/ejn.14583 · Cited by 17 · see citing works

Longitudinal Monitoring of Sex-Related in vivo Metabolic Changes in the Brain of Alzheimer's Disease Transgenic Mouse Using Magnetic Resonance Spectroscopy

van Duijn, S., Nabuurs, R. J. A., van Duinen, S. G., Natté, R., van Buchem, M. A., & Alia, A. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-122188 · Cited by 16 · see citing works

Magnetic resonance imaging of glutamate in neuroinflammation

Chen, Y., Dai, Z., Shen, Z., Lin, G., Zhuang, C., Li, H. J., & Wu, R. (2016) · Radiology of Infectious Diseases · doi:10.1016/j.jrid.2016.03.006 · Cited by 16 · see citing works

1H-MRS neurometabolites and associations with neurite microstructures and cognitive functions in amnestic mild cognitive impairment

Gozdas, E., Hinkley, L. M., Fingerhut, H., Dacorro, L., Gu, M., Sacchet, M. D., Hurd, R. E., & Hosseini, S. M. H. (2022) · NeuroImage Clinical · doi:10.1016/j.nicl.2022.103159 · Cited by 15 · see citing works

Microbiota-gut-brain axis dysregulation in Alzheimer’s disease and its modulation through probiotic supplementation

Marizzoni, M., Mombelli, E., Alboni, S., Rosa, M., Moretti, D. V., Mirabelli, P., Coppola, L., Luongo, D., Salamone, D., Saleri, S., et al. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.106138 · Cited by 14 · see citing works

Cholinergic neurotransmission in the brain of streptozotocin-induced rat model of sporadic Alzheimer’s disease: long-term follow up

Knezović, A., & Šalković‐Petrišić, M. (2025) · Journal of Neural Transmission · doi:10.1007/s00702-025-02887-2 · Cited by 14 · see citing works

Automated algorithm to measure changes in medial temporal lobe volume in Alzheimer disease

Kazemifar, S., Drozd, J. J., Rajakumar, N., BORRIE, M. J., & Bartha, R. (2014) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2014.01.033 · Cited by 14 · see citing works

Hippocampal Neurochemical Profile and Glucose Transport Kinetics in Patients With Type 1 Diabetes

Bednařík, P., Henry, P., Khowaja, A., Rubin, N., Kumar, A. D., Deelchand, D. K., Eberly, L. E., Seaquist, E. R., Öz, G., & Moheet, A. A. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz062 · Cited by 14 · see citing works

Hydrogen Proton Magnetic Resonance Spectroscopy in Multidomain Amnestic Mild Cognitive Impairment and Vascular Cognitive Impairment Without Dementia

Chen, S., Cai, Q., Shen, Y., Chuanxiao, X., Zhou, H., & Zhao, Z. (2016) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317515628052 · Cited by 15 · see citing works

Study of ~1H MR Spectroscopy in Hippocampus Metabolites of Alzheimer Disease

Jianpin, Q. (2009) · Radiologic Practice

Brain Glutamate Levels Are Decreased in Alzheimer’s Disease: A Magnetic Resonance Spectroscopy Study

Fayed, N., Modrego, P. J., Rojas-Salinas, G., & Aguilar, K. (2011) · American Journal of Alzheimer's Disease & Other Dementias® · doi:10.1177/1533317511421780 · Cited by 128 · see citing works

Metabolic Changes in Patients with Alzheimer's Disease Assessed by High Field Proton Magnetic Resonance Spectroscopy

Feng, X. (2010) · Chinese Computed Medical Imaging

Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and alzheimer disease

Wang, Z., Zhao, C., Lei, Y., Zhou, W., & Li, K. (2009) · Acta Radiologica · doi:10.1080/02841850802709219 · Cited by 64 · see citing works

P2–349: Analysis of metabolite levels and ratios in age matched controls, mild cognitive impairment, and Alzheimer's disease converters using 1H magnetic resonance spectroscopy

Mueller, C., Bartnik‐Olson, B., Patra, S., Baqai, W. K., Petersen, F. F., Holshouser, B. A., & Kirsch, W. M. (2006) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2006.05.1189